Skip to main content
Erschienen in: Journal of Cancer Survivorship 1/2011

01.03.2011

Complementary and alternative medicine use among cancer survivors: a population-based study

verfasst von: Jun James Mao, Christina Shearer Palmer, Kaitlin Elizabeth Healy, Krupali Desai, Jay Amsterdam

Erschienen in: Journal of Cancer Survivorship | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The use of complementary and alternative medicine (CAM) among cancer survivors is high, yet less is known about reasons behind such use or the communication of CAM with conventional medical providers.

Methods

Cross-sectional, multivariate logistic regression models were developed to evaluate the similarities and differences between cancer survivors and non-cancer controls in the 2007 National Health Interview Survey with 23,393 participants, including 1,471 cancer survivors.

Results

Among cancer survivors, 66.5% reported ever using CAM and 43.3% having used CAM in the past year. When compared with the general population, cancer survivors used CAM more often for general disease prevention, immune enhancement, and for pain (Adjusted Odds Ratio [AOR] 1.27, 95% Confidence Interval [CI] 1.10–1.48; AOR 1.32, 95% CI 1.05–1.62; AOR 1.42, 95% CI 1.05–1.92, respectively). Cancer survivors were more likely to use CAM because of recommendations from their provider (AOR 1.54, 95% CI 1.26–1.88) and were more likely to disclose their CAM use to their provider (AOR 1.45, 95% CI 1.22–1.72).

Discussions/Conclusions

When compared to the general population, cancer survivors were more likely to use CAM and communicate this use with providers, indicating a growing integration of CAM in conventional medical care.

Implications for Cancer Survivors

Cancer survivors are more likely than the general population to communicate CAM use with providers, suggesting greater integration of CAM use in conventional care. However, the majority of CAM use is still not being communicated to providers, indicating an important area for improvement in patient-centered care.
Literatur
1.
Zurück zum Zitat Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. (eds). SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010. Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, et al. (eds). SEER Cancer Statistics Review, 1975–2007, National Cancer Institute. Bethesda, MD, http://​seer.​cancer.​gov/​csr/​1975_​2007/​, based on November 2009 SEER data submission, posted to the SEER web site, 2010.
2.
Zurück zum Zitat Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 1998;83(4):777–82.CrossRefPubMed Ernst E, Cassileth BR. The prevalence of complementary/alternative medicine in cancer: a systematic review. Cancer. 1998;83(4):777–82.CrossRefPubMed
3.
Zurück zum Zitat Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505–14.PubMed Richardson MA, Sanders T, Palmer JL, Greisinger A, Singletary SE. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol. 2000;18(13):2505–14.PubMed
4.
Zurück zum Zitat Cassileth BR, Vickers AJ. High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. J Clin Oncol. 2005;23(12):2590–2.CrossRefPubMed Cassileth BR, Vickers AJ. High prevalence of complementary and alternative medicine use among cancer patients: implications for research and clinical care. J Clin Oncol. 2005;23(12):2590–2.CrossRefPubMed
5.
Zurück zum Zitat Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007;7:4.CrossRefPubMed Boon HS, Olatunde F, Zick SM. Trends in complementary/alternative medicine use by breast cancer survivors: comparing survey data from 1998 and 2005. BMC Womens Health. 2007;7:4.CrossRefPubMed
6.
Zurück zum Zitat Mao JJ, Farrar JT, Xie SX, Bowman MA, Armstrong K. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med. 2007;15(1):21–9.CrossRefPubMed Mao JJ, Farrar JT, Xie SX, Bowman MA, Armstrong K. Use of complementary and alternative medicine and prayer among a national sample of cancer survivors compared to other populations without cancer. Complement Ther Med. 2007;15(1):21–9.CrossRefPubMed
7.
Zurück zum Zitat Goldstein MS, Lee JH, Ballard-Barbash R, Brown ER. The use and perceived benefit of complementary and alternative medicine among Californians with cancer. Psychooncology. 2008;17(1):19–25.CrossRefPubMed Goldstein MS, Lee JH, Ballard-Barbash R, Brown ER. The use and perceived benefit of complementary and alternative medicine among Californians with cancer. Psychooncology. 2008;17(1):19–25.CrossRefPubMed
8.
Zurück zum Zitat Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med. 2007;20(5):434–43.CrossRefPubMed Mao JJ, Armstrong K, Bowman MA, Xie SX, Kadakia R, Farrar JT. Symptom burden among cancer survivors: impact of age and comorbidity. J Am Board Fam Med. 2007;20(5):434–43.CrossRefPubMed
9.
Zurück zum Zitat Rowland JH, Baker F. Introduction: resilience of cancer survivors across the lifespan. Cancer. 2005;104(11 Suppl):2543–8.CrossRefPubMed Rowland JH, Baker F. Introduction: resilience of cancer survivors across the lifespan. Cancer. 2005;104(11 Suppl):2543–8.CrossRefPubMed
10.
Zurück zum Zitat Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104(11 Supplement):2565–76.CrossRefPubMed Baker F, Denniston M, Smith T, West MM. Adult cancer survivors: how are they faring? Cancer. 2005;104(11 Supplement):2565–76.CrossRefPubMed
11.
Zurück zum Zitat Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. Jama. 1998;280(18):1569–75.CrossRefPubMed Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey. Jama. 1998;280(18):1569–75.CrossRefPubMed
12.
Zurück zum Zitat Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;27(343):1–19. Barnes PM, Powell-Griner E, McFann K, Nahin RL. Complementary and alternative medicine use among adults: United States, 2002. Adv Data. 2004;27(343):1–19.
13.
Zurück zum Zitat Henderson JW, Donatelle RJ. The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer. Psycho-oncology. 2003;12(1):59–67.CrossRefPubMed Henderson JW, Donatelle RJ. The relationship between cancer locus of control and complementary and alternative medicine use by women diagnosed with breast cancer. Psycho-oncology. 2003;12(1):59–67.CrossRefPubMed
14.
Zurück zum Zitat Singh H, Maskarinec G, Shumay DM. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer. Integr Cancer Ther. 2005;4(2):187–94.CrossRefPubMed Singh H, Maskarinec G, Shumay DM. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer. Integr Cancer Ther. 2005;4(2):187–94.CrossRefPubMed
15.
Zurück zum Zitat Astin JA, Reilly C, Perkins C, Child WL. Breast cancer patients’ perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation. J Soc Integr Oncol. 2006;4(4):157–69.CrossRefPubMed Astin JA, Reilly C, Perkins C, Child WL. Breast cancer patients’ perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation. J Soc Integr Oncol. 2006;4(4):157–69.CrossRefPubMed
16.
Zurück zum Zitat Shen J, Andersen R, Albert PS, Wenger N, Glaspy J, Cole M, et al. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med. 2002;2:8.CrossRefPubMed Shen J, Andersen R, Albert PS, Wenger N, Glaspy J, Cole M, et al. Use of complementary/alternative therapies by women with advanced-stage breast cancer. BMC Complement Altern Med. 2002;2:8.CrossRefPubMed
17.
Zurück zum Zitat Humpel N, Jones SC. Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors. Eur J Cancer Care Engl. 2006;15(4):362–8.CrossRefPubMed Humpel N, Jones SC. Gaining insight into the what, why and where of complementary and alternative medicine use by cancer patients and survivors. Eur J Cancer Care Engl. 2006;15(4):362–8.CrossRefPubMed
18.
Zurück zum Zitat Carpenter JS, Andrykowski MA, Sloan P, Cunningham L, Cordova MJ, Studts JL, et al. Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol. 1998;51(12):1285–92.CrossRefPubMed Carpenter JS, Andrykowski MA, Sloan P, Cunningham L, Cordova MJ, Studts JL, et al. Postmastectomy/postlumpectomy pain in breast cancer survivors. J Clin Epidemiol. 1998;51(12):1285–92.CrossRefPubMed
19.
Zurück zum Zitat Barg FK, Cronholm PF, Straton JB, Keddem S, Knott K, Grater J, et al. Unmet psychosocial needs of Pennsylvanians with cancer: 1986–2005. Cancer. 2007;110(3):631–9.CrossRefPubMed Barg FK, Cronholm PF, Straton JB, Keddem S, Knott K, Grater J, et al. Unmet psychosocial needs of Pennsylvanians with cancer: 1986–2005. Cancer. 2007;110(3):631–9.CrossRefPubMed
20.
Zurück zum Zitat Mao JJ, Palmer SC, Straton J, Cronholm P, Keddem S, Knott K, et al. Cancer survivors with unmet needs were more likely to use complementary and alternative medicine. J Cancer Surviv. 2008. doi:101007/s11764-008-0052-3.PubMed Mao JJ, Palmer SC, Straton J, Cronholm P, Keddem S, Knott K, et al. Cancer survivors with unmet needs were more likely to use complementary and alternative medicine. J Cancer Surviv. 2008. doi:101007/​s11764-008-0052-3.PubMed
21.
Zurück zum Zitat Ashikaga T, Bosompra K, O’Brien P, Nelson L. Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer. 2002;10(7):542–8.CrossRefPubMed Ashikaga T, Bosompra K, O’Brien P, Nelson L. Use of complimentary and alternative medicine by breast cancer patients: prevalence, patterns and communication with physicians. Support Care Cancer. 2002;10(7):542–8.CrossRefPubMed
22.
Zurück zum Zitat Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psychooncology. 2002;11(3):212–20.CrossRefPubMed Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients’ perspectives. Psychooncology. 2002;11(3):212–20.CrossRefPubMed
23.
Zurück zum Zitat Monti DA, Yang J. Complementary medicine in chronic cancer care. Semin Oncol. 2005;32(2):225–31.CrossRefPubMed Monti DA, Yang J. Complementary medicine in chronic cancer care. Semin Oncol. 2005;32(2):225–31.CrossRefPubMed
24.
Zurück zum Zitat Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin. 2005;55(2):109–16.CrossRefPubMed Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin. 2005;55(2):109–16.CrossRefPubMed
25.
Zurück zum Zitat Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999;340(22):1733–9.CrossRefPubMed Burstein HJ, Gelber S, Guadagnoli E, Weeks JC. Use of alternative medicine by women with early-stage breast cancer. N Engl J Med. 1999;340(22):1733–9.CrossRefPubMed
26.
Zurück zum Zitat Yap KP, McCready DR, Fyles A, Manchul L, Trudeau M, Narod S. Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery. Breast J. 2004;10(6):481–6.CrossRefPubMed Yap KP, McCready DR, Fyles A, Manchul L, Trudeau M, Narod S. Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery. Breast J. 2004;10(6):481–6.CrossRefPubMed
27.
Zurück zum Zitat Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002;137(11):889–903.PubMed Weiger WA, Smith M, Boon H, Richardson MA, Kaptchuk TJ, Eisenberg DM. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002;137(11):889–903.PubMed
28.
Zurück zum Zitat Saper RB, Kales SN, Paquin J, Burns MJ, Eisenberg DM, Davis RB, et al. Heavy metal content of ayurvedic herbal medicine products. Jama. 2004;292(23):2868–73.CrossRefPubMed Saper RB, Kales SN, Paquin J, Burns MJ, Eisenberg DM, Davis RB, et al. Heavy metal content of ayurvedic herbal medicine products. Jama. 2004;292(23):2868–73.CrossRefPubMed
29.
Zurück zum Zitat Matthews SC, Camacho A, Mills PJ, Dimsdale JE. The internet for medical information about cancer: help or hindrance? Psychosomatics. 2003;44(2):100–3.CrossRefPubMed Matthews SC, Camacho A, Mills PJ, Dimsdale JE. The internet for medical information about cancer: help or hindrance? Psychosomatics. 2003;44(2):100–3.CrossRefPubMed
30.
Zurück zum Zitat Schmidt K, Ernst E. Assessing websites on complementary and alternative medicine for cancer. Ann Oncol. 2004;15(5):733–42.CrossRefPubMed Schmidt K, Ernst E. Assessing websites on complementary and alternative medicine for cancer. Ann Oncol. 2004;15(5):733–42.CrossRefPubMed
32.
Zurück zum Zitat Yabroff K, Lawrence W, Clauser S, Davis W, Brown M. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322–30.CrossRefPubMed Yabroff K, Lawrence W, Clauser S, Davis W, Brown M. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96(17):1322–30.CrossRefPubMed
36.
Zurück zum Zitat Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;10(12):1–23. Barnes PM, Bloom B, Nahin RL. Complementary and alternative medicine use among adults and children: United States, 2007. Natl Health Stat Report. 2008;10(12):1–23.
37.
Zurück zum Zitat American Statistical Association. Section on survey research methods: summary of survey analysis software. 2005. American Statistical Association. Section on survey research methods: summary of survey analysis software. 2005.
38.
Zurück zum Zitat Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;30(18):1–14. Nahin RL, Barnes PM, Stussman BJ, Bloom B. Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report. 2009;30(18):1–14.
39.
Zurück zum Zitat Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814–30.CrossRefPubMed Demark-Wahnefried W, Aziz NM, Rowland JH, Pinto BM. Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol. 2005;23(24):5814–30.CrossRefPubMed
40.
Zurück zum Zitat Cohen L, Markman M. Integrative oncology: incorporating complementary medicine into conventional cancer care. Totowa: Humana; 2008. Cohen L, Markman M. Integrative oncology: incorporating complementary medicine into conventional cancer care. Totowa: Humana; 2008.
41.
Zurück zum Zitat Brauer JA, El Sehamy A, Metz JM, Mao JJ. Complementary and alternative medicine and supportive care at leading cancer centers: a systematic analysis of websites. J Altern Complement Med. 2010;16(2):183-6.CrossRefPubMed Brauer JA, El Sehamy A, Metz JM, Mao JJ. Complementary and alternative medicine and supportive care at leading cancer centers: a systematic analysis of websites. J Altern Complement Med. 2010;16(2):183-6.CrossRefPubMed
42.
Zurück zum Zitat Cassileth BR. Society for integrative oncology first international conference, New York City, November 2004. Welcome address. J Soc Integr Oncol. 2005;3(4):121.CrossRefPubMed Cassileth BR. Society for integrative oncology first international conference, New York City, November 2004. Welcome address. J Soc Integr Oncol. 2005;3(4):121.CrossRefPubMed
43.
Zurück zum Zitat Gardiner P, Kemper KJ, Legedza A, Phillips RS. Factors associated with herb and dietary supplement use by young adults in the United States. BMC Complement Altern Med. 2007;7:39.CrossRefPubMed Gardiner P, Kemper KJ, Legedza A, Phillips RS. Factors associated with herb and dietary supplement use by young adults in the United States. BMC Complement Altern Med. 2007;7:39.CrossRefPubMed
44.
Zurück zum Zitat Richardson MA, Masse LC, Nanny K, Sanders C. Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer. 2004;12(11):797–804.CrossRefPubMed Richardson MA, Masse LC, Nanny K, Sanders C. Discrepant views of oncologists and cancer patients on complementary/alternative medicine. Support Care Cancer. 2004;12(11):797–804.CrossRefPubMed
45.
Zurück zum Zitat Sleath B, Callahan L, DeVellis RF, Sloane PD. Patients’ perceptions of primary care physicians’ participatory decision-making style and communication about complementary and alternative medicine for arthritis. J Altern Complement Med. 2005;11(3):449–53.CrossRefPubMed Sleath B, Callahan L, DeVellis RF, Sloane PD. Patients’ perceptions of primary care physicians’ participatory decision-making style and communication about complementary and alternative medicine for arthritis. J Altern Complement Med. 2005;11(3):449–53.CrossRefPubMed
46.
Zurück zum Zitat Swenson SL, Buell S, Zettler P, White M, Ruston DC, Lo B. Patient-centered communication: do patients really prefer it? J Gen Intern Med. 2004;19(11):1069–79.CrossRefPubMed Swenson SL, Buell S, Zettler P, White M, Ruston DC, Lo B. Patient-centered communication: do patients really prefer it? J Gen Intern Med. 2004;19(11):1069–79.CrossRefPubMed
47.
Zurück zum Zitat Roberts C, Benjamin H, Chen L, Gavigan M, Gesme DH, McCarthy P, et al. Assessing communication between oncology professionals and their patients. J Cancer Educ. 2005;20(2):113–8.CrossRefPubMed Roberts C, Benjamin H, Chen L, Gavigan M, Gesme DH, McCarthy P, et al. Assessing communication between oncology professionals and their patients. J Cancer Educ. 2005;20(2):113–8.CrossRefPubMed
48.
Zurück zum Zitat Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, et al. Race, gender, and partnership in the patient-physician relationship. Jama. 1999;282(6):583–9.CrossRefPubMed Cooper-Patrick L, Gallo JJ, Gonzales JJ, Vu HT, Powe NR, Nelson C, et al. Race, gender, and partnership in the patient-physician relationship. Jama. 1999;282(6):583–9.CrossRefPubMed
49.
Zurück zum Zitat Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol. 2001;153(3):299–306.CrossRefPubMed Desai MM, Bruce ML, Desai RA, Druss BG. Validity of self-reported cancer history: a comparison of health interview data and cancer registry records. Am J Epidemiol. 2001;153(3):299–306.CrossRefPubMed
Metadaten
Titel
Complementary and alternative medicine use among cancer survivors: a population-based study
verfasst von
Jun James Mao
Christina Shearer Palmer
Kaitlin Elizabeth Healy
Krupali Desai
Jay Amsterdam
Publikationsdatum
01.03.2011
Verlag
Springer US
Erschienen in
Journal of Cancer Survivorship / Ausgabe 1/2011
Print ISSN: 1932-2259
Elektronische ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-010-0153-7

Weitere Artikel der Ausgabe 1/2011

Journal of Cancer Survivorship 1/2011 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.